Invasive Saccharomyces Infection: A Comprehensive Review
The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Saccharomyces cerevisiae (also known as "baker's yeast" or "brewer's yeast") is mostly considered to be an occasional digestive commensal. However, since the 1990s, there have been a growing number of reports about its implication as an etiologic agent of invasive infection. A particular feature of such infections is their association with a probiotic preparation of Saccharomyces boulardii (a subtype of S. cerevisiae) for treatment various diarrheal disorders. METHODS: We collected published case reports, through May 2005, of invasive Saccharomyces infection by use of a Medline query. Epidemiological and clinical charts and therapeutic strategies were analyzed. RESULTS: We found 92 cases of Saccharomyces invasive infection. Predisposing factors were similar to those of invasive candidiasis, with intravascular catheter and antibiotic therapy being the most frequent. Blood was the most frequent site of isolation (for 72 patients). S. boulardii accounted for 51.3% of fungemias and was exclusively isolated from blood. Compared with patients infected with S. cerevisiae, patients infected with S. boulardii were more frequently immunocompetent and had a better prognosis. Saccharomyces invasive infection was clinically indistinguishable from an invasive candidiasis. Overall, S. cerevisiae clinical isolates exhibited low susceptibility to amphotericin B and azole derivatives. However, global outcome was favorable in 62% of the cases. Treatment with intravenous amphotericin B and fluconazole, in combination with central vascular catheter removal, were effective therapeutic options. CONCLUSION: Saccharomyces organisms should now be added to the growing list of emerging fungal pathogens. Special caution should be taken regarding the use of S. boulardii probiotic preparations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple cases of disseminated infection have been identified in apparent association with this probiotic, particularly in immune-suppressed individuals (39).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [39]
In the citing paper
“In a few case studies, however, S. cerevisiae has been implicated in catheter-associated infections with mixed-species biofilms in patients in intensive care units (ICUs)”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
In the citing paper
“and it is able to form a thin biofilm consisting of round, budding yeast-form cells and pseudohyphal cells in vitro (26, 50, 128, 164).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“We only considered proven infection, based on the definitions of the Invasive Fungal Infection Cooperative Group of the European Organization for Research and Treatment of Cancer–Mycosis Study Group of the National Institute of Allergy and Infectious Diseases cooperative group [19]: fungemia, isolation from normally s…”
MethodNEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Medical Mycology. The Pathogenic Fungi and Pathogenic Actinomycetes.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-4-514_1 · Cited by 847
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“Despite this spectrum of susceptibility, a favorable outcome was observed in 63% of cases revealed in our literature search, which is a slightly higher percentage than that reported for cases of invasive candidiasis [87].”
ResultProtection from gastrointestinal diseases with the use of probiotics
Marteau, P. R., Vrese, M. D., Cellier, C. J., & Schrezenmeir, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.430s · Cited by 596
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“35[77] 76 years, F DNA fingerprinting Diabetes, heart surgery No Yes Yes Yes FLU NS Death 36 [771 72 years, F DNA fingerprinting Heart surgery No Yes Yes Yes None NS Death 37 [77] 74 years, F DNA fingerprinting Rheumatoid arthritis, corticosteroid therapy, heart surgery NS No Yes Yes FLU NS Death”
BackgroundFUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE
EUBINSTE1N, E., NOKIEGA, E. R., SIMBEEKOFF, M. S., HOLZMAN, E., & RAHAL, J. J. (1975) · Medicine · doi:10.1097/00005792-197507000-00003 · Cited by 275 · cited 1×
“1 [231 54 years, F Blood Urine Diphtheroids Valvular prosthesis No Yes Yes AmB Yes Favorable 2 [24] 38 years, M .”
BackgroundNew Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J., & Rolston, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 259
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann-Lacroix, C., Jobert, A., Viard, J. P., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253 · cited 5×
“Hand transmission has been suggested in these latter cases [5].”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 9
- 2001, 11, 19
- Rubinstein, 1975, Medicine, 54, 331
- Eschete, 1980, Archives of Internal Medicine, 140, 1539, 10.1001/archinte.1980.00330220085032 · doi:10.1001/archinte.1980.00330220085032
- 1997, Bulletin de la Soci t de pathologie exotique (1990), 90, 307
- Pavese, 1999, Pathologie-biologie, 47, 579
- Feld, 1982, The Journal of Rheumatology, 9, 637
- Kirsch, 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 34, 229
- Zunic, 1991, Th rapie, 46, 498
- Pletincx, 1995, Journal of pediatric gastroenterology and nutrition, 21, 113, 10.1097/00005176-199507000-00022 · doi:10.1097/00005176-199507000-00022 · Paper page
Cited by
Items 201–300 of 368
Pfliegler, W. P., Boros, E., Pázmándi, K., Jakab, Á., Zsuga, I., Kovács, R., Urbán, E. Z., Antunovics, Z., Bácsi, A., Sipiczki, M., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601099 · Cited by 11
Ma, J., & Dubberke, E. R. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4377 · Cited by 12
Infecção por Saccharomyces cerevisae: uma infecção atípica em UTI
da Silva, F. H. A., Paço, F. R., Reis, E. P., & Amaral, V. H. B. (2011) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2011000100017 · Cited by 11
“Nos humanos, o gênero Saccharomyces pode estar presente como colonizante na mucosa gastrointestinal, respiratória e urinária em pacientes com doenças de base.(2-4) Apesar de rara, a infecção por fungos “incomuns” vem aumentando em nosso meio,(2,5) sendo o Saccharomyces cerevisae reconhecido como germe emergente, com u…”
BackgroundInfluentialNovel Management Strategies in the Treatment of Severe Clostridium difficile Infection
Nassour, I., Carchman, E. H., Simmons, R. L., & Zuckerbraun, B. S. (2012) · Advances in Surgery · doi:10.1016/j.yasu.2012.03.009 · Cited by 9
Ahmad, S., Abbasi, W. M., & Rehman, T. (2018) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0127 · Cited by 9
Du, M., Li, G., Wang, Z., Ge, Y., & Liu, F. (2021) · Applied Optics · doi:10.1364/ao.415684 · Cited by 9
Pinto, G., de Lima, L. L. P., Pedra, T., Assumpção, A. M., Morgado, S. M., & Mascarenhas, L. A. (2021) · Access Microbiology · doi:10.1099/acmi.0.000250 · Cited by 10
“In humans, the genus Saccharomyces may be present as a colonizer of the gastrointestinal, respiratory and urinary mucosa [8], and also in patients with underlying diseases [3, 9, 10].”
InfluentialWhat colorectal surgeons should know about probiotics: a review
Kvasnovsky, C., Bjarnason, I., & Papagrigoriadis, S. (2015) · Colorectal Disease · doi:10.1111/codi.13046 · Cited by 8
Microbial-based cleaning products as a potential risk to human health: A review
Maestra, S. L., D’Agostini, F., Geretto, M., & Micale, R. T. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.09.013 · Cited by 7
Letsiou, S., Pyrovolou, K., Konteles, S. J., Trapali, M., Κρίσιλια, Σ. Ε., Kokla, V., Apostolaki, A., Founda, V., Houhoula, D. P., & Batrinou, A. (2024) · Applied Sciences · doi:10.3390/app14051899 · Cited by 11
“The low susceptibility of S. cerevisiae to some azoles has already been documented, and although the yeast is considered GRAS (generally recognized as safe), there have been cases in which it has caused invasive infection [37].”
Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro
Pérez‐Torrado, R., & Querol, A. (2017) · F1000Research · doi:10.12688/f1000research.11782.2 · Cited by 8
Téblick, A., Jansens, H., Dams, K., Somville, F. J. M. P., & Jorens, P. G. (2017) · Acta Clinica Belgica · doi:10.1080/17843286.2017.1398439 · Cited by 9
“digestive commensal linked to contaminated food [4].”
BackgroundDifficult to Treat Infections in the Burn Patient
Lago, K., Decker, C. F., Chung, K. K., & Blyth, D. M. (2020) · Surgical Infections · doi:10.1089/sur.2020.128 · Cited by 8
Rhodotorula, Saccharomyces, Malassezia, Trichosporon, Blastoschizomyces, and Sporobolomyces
Vazquez, J. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_13 · Cited by 8
“Endocarditis. Three documented cases of endocarditis have been reported [ 43 , 51, 53].”
BackgroundResultInfluentialClostridium difficile in paediatric populations
Upton, D. A., & Canadian Paediatric Society (2014) · Paediatrics & Child Health · doi:10.1093/pch/19.1.43 · Cited by 10
“[59] However, although the risk is believed to be low, the use of S boulardii has been associated with fungemia in immunocompromised patients and in patients with central venous lines.[66]”
BackgroundImre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pfliegler, W. P., & Pócsi, I. (2022) · Journal of Fungi · doi:10.3390/jof8050522 · Cited by 9
Davies, E., Shipp, A., Hawkes, R., & Wynn, R. F. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001403 · Cited by 7
Corrêa-Junior, D., de Andrade, I. B., Alves, V., Araújo, G. R. D. S., & Frasés, S. (2022) · Microorganisms · doi:10.3390/microorganisms10112223 · Cited by 7
“There is no consensus on the treatment of Saccharomyces infection, favoring the use of fluconazole, voriconazole, flucytosine, AmB, and even the association of AmB with fluconazole [108].”
BackgroundCohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657453 · Cited by 10
“boulardii, se ha asociado con fungemia en pacientes inmunocomprometidos y en pacientes con lı́neas intravenosas centrales, y se deberı́a evitar en pacientes crı́ticamente enfermos.(227) No existen pruebas contundentes de que otros pro-”
BackgroundChwastowski, J., Wójcik, K., Kołoczek, H., Oszczęda, Z., Khachatryan, K., & Tomasik, P. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2169708 · Cited by 6
“[52] Y. lipolytica yeast species synthesize a wide group of lipases and other hydrolytic enzymes, microbial oil, citric acid, erythritol, and γ-decalactone.”
BackgroundKrylov, V. B., Kuznetsov, A. N., Polyanskaya, A. V., Tsarapaev, P. V., Yashunsky, D. V., Кушлинский, Н. Е., & Nifantiev, N. E. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1296828 · Cited by 6
Alroumi, F., Sarwar, A., Grgurich, P. E., Lei, Y., Hudcova, J., & Craven, D. E. (2012) · Hospital Practice · doi:10.3810/hp.2012.02.949 · Cited by 8
Infection invasive à Saccharomyces cerevisiae : le premier cas rapporté au Maroc
Maleb, A., Sebbar, E.-H., Frikh, M., Boubker, S., MOUSSAOUI, A., Mekkaoui, A. E., Khannoussi, W., Kharrasse, G., Belefquih, B., Lemnouer, A., et al. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.01.008 · Cited by 6
Saccharomyces cerevisiae show low levels of traversal across the human blood brain barrier in vitro
Pérez‐Torrado, R., & Querol, A. (2017) · F1000Research · doi:10.12688/f1000research.11782.1 · Cited by 6
Stefanini, I., Albanese, D., Sordo, M., Legras, J., Filippo, C. D., Cavalieri, D., & Donati, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-15729-3 · Cited by 6
Arthur, P. K., Yeboah, A. B., Issah, I., Balapangu, S. S., Kwofie, S. K., Asimeng, B. O., Foster, E. J., & Tiburu, E. K. (2019) · Biosensors · doi:10.3390/bios9010045 · Cited by 7
Clostridium difficile Infection
Germansky, K. A., & Kelly, C. P. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2011.12.002 · Cited by 6
Clostridium difficile-Associated Disease in the New Millennium: "The Perfect Storm" Has Arrived
Owens, R. C., & Valenti, A. J. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3180686491 · Cited by 6
Disseminated Saccharomyces cerevisiae infection in advanced HIV: a literature review
Li, L. X., Gupta, A., Hamill, M. M., Zhang, S. X., & Manabe, Y. C. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.02.009 · Cited by 5
Commensalism: The Case of the Human Zymobiome
Inácio, J., & Daniel, H.-M. (2017) · Springer eBooks · doi:10.1007/978-3-319-61575-2_8 · Cited by 5
Scharf, S. A., Bartels, A., Kondakci, M., Haas, R. R., Pfeffer, K., & Henrich, B. (2021) · Medical Mycology · doi:10.1093/mmy/myab045 · Cited by 7
An Update on Probiotic Safety and Efficacy
Naon, H. (2015) · Cited by 5
Multani, A., Rustagi, A., Epstein, D. J., Gómez, C. A., Budvytiene, I., Banaei, N., Brown, J. W., & Liu, A. Y. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.03.011 · Cited by 5
Exploring accidental virulence
Smith, D. F. Q. (2023) · eLife · doi:10.7554/elife.94556 · Cited by 5
Saccharomyces cerevisiae fungemias: how heterogenous is their management?
Diop, C. S., Descy, J., Sacheli, R., Meex, C., Sinpetrean, A., Layios, N., & Hayette, M. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116343 · Cited by 5
Slivka, M. V., Sharga, B. M., Pylypiv, D. B., Aleksyk, H., Korol, N. I., Fizer, M. M., Fedurcya, O. I., Pshenychnyi, O. G., & Mariychuk, R. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146845 · Cited by 9
“A low susceptibility to amphotericin B and to azole derivatives was observed [39].”
Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab
Abdin, A. D., Suffo, S., Alnaggar, D., Daas, L., & Seitz, B. (2020) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2020.100591 · Cited by 4
“Saccharomyces organisms, also known as “baker's yeast” or “brewer's yeast”, are increasingly reported causes for invasive infections.(3) They are common in nature and can be found on plants in soil or included in some health foods.”
BackgroundJain, N., Jansone, I., Obidenova, T., Sīmanis, R., Meisters, J., Straupmane, D., & Reinis, A. (2021) · Life · doi:10.3390/life11101002 · Cited by 6
Ekdahl, L. I., Salcedo, J. A., Dungan, M. M., Mason, D. V., Myagmarsuren, D., & Murphy, H. A. (2023) · eLife · doi:10.7554/elife.81056 · Cited by 6
“…is also an opportunistic pathogen capable of infecting immunocompromised individuals, with reports of infections increasing ( Aucott et al., 1990 ; Muñoz et al., 2005 ; Llopis et al., 2014 ; Enache-Angoulvant and Hennequin, 2005 ; Hennequin et al., 2000 ; Pérez-Torrado and Querol, 2015 ).”
BackgroundGlinka, P., Nowacka, K., Kulesza, K., Ejdys, E., & Dynowska, M. (2018) · PubMed · doi:10.17420/ap6403.152 · Cited by 4
Apoptosis - Triggering Effects: UVB-irradiation and Saccharomyces cerevisiae.
Behzadi, P., & Behzadi, E. (2012) · Europe PMC (PubMed Central) · Cited by 4
Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015
Carmo, J., Marques, S., Chapim, I., Túlio, M. A., Rodrigues, J. P., Bispo, M., & Chagas, C. (2015) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpge.2015.07.006 · Cited by 7
Singh, N. K., & Hyun, D. Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00192-6 · Cited by 4
Lijon, M. B., Matsuura, Y., Ukita, T., Arakawa, K., & MIYAMOTO, T. (2025) · Microorganisms · doi:10.3390/microorganisms13092017 · Cited by 4
“Other species, including Rhodotorula mucilaginosa and even S. cerevisiae, have also been reported to rarely cause infection through food, particularly in immunocompromised individuals [21,22].”
Harmath, A., Németh, B., Pócsi, I., Majoros, L., Pfliegler, W. P., & Kovács, R. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02750-25 · Cited by 4
Probiotic paradox: Saccharomyces cerevisiae fungemia after S. boulardii use in severe pancreatitis
Dholakia, V., Sain, S., Jena, S. S., & Nundy, S. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02452 · Cited by 4
“In a comprehensive review of more than 90 cases of S. cerevisiae fungemia, the most consistent risk factor identified was the use of pro-biotics containing S. boulardii [13].”
Climate Change Impacts on Environmental Fungi: Human Health and Fungal Disease
Irizarry, P. R., Smith, D. F. Q., & Gusa, A. A. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_305 · Cited by 6
Oladugba, E. O. (2022) · Journal of applied science and environmental management · doi:10.4314/jasem.v26i11.2 · Cited by 3
“Similarly, the finding of Saccharomyces cerevisiae in urogential tracts specimens is in agreement with previous findings (Enache–Angoulvant and Hennequin, 2005).”
Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine model
Hernández‐Haro, C., Llopis, S., Molina, M., Monteoliva, L., & Gil, C. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.08.008 · Cited by 4
Roig, P., de Llanos, R., Gil, J. V., & Fernández-Espinar, M. T. (2013) · Annals of Microbiology · doi:10.1007/s13213-013-0605-1 · Cited by 3
“…numerous cases of clinical infections caused by S. cerevisiae have been reported in recent decades as reflected in two reviews on this topic (Enache-Angoulvant and Hennequin 2005; Muñoz et al. 2005) and in more recent references (Richter et al. 2005; de Llanos et al. 2006b; Williams et al.…”
BackgroundInfluentialDNA Barcoding of Yeasts from Selected Bulgarian Food Products
Gouliamova, D. E., Dimitrov, R., & Stoilova-Disheva, M. M. (2012) · Biotechnology & Biotechnological Equipment · doi:10.5504/50yrtimb.2011.0006 · Cited by 3
Saccharomyces cerevisiae fungemia in inflammatory bowel disease
Barman, P., Pande, R., Sengupta, S., & Bhalla, V. (2017) · Tropical Gastroenterology · doi:10.7869/tg.393 · Cited by 3
“It is present as commensal in human Case Report Tropical Gastroenterology 2017;38(1):50-52”
BackgroundBilateral fungal infection inducing a serpiginous-like picture
Fernández‐Vega, Á., Fernández-Vega, C., Sanz, B. F.-V., Peláez, M. T. R., & Merayo-Llovés, J. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120908726 · Cited by 3
The Role of Probiotics in the Treatment and Prevention of Infectious Diarrhea in Children
Sarker, S. A., & Fuchs, G. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-289-6_11 · Cited by 2
“Fungemia with S. boulardii has been reported in about 50 patients with invasive candidiasis or with intravascular catheter and antibiotic therapy [ 86 ] ; indwelling central venous catheter was the main risk factor identified in this study.”
BackgroundA Case of Recurrent Clostridium difficile Diarrhea
Pakyz, A. L. (2007) · The Consultant Pharmacist · doi:10.4140/tcp.n.2007.249 · Cited by 3
(2011) · Elsevier eBooks · doi:10.1016/b978-0-444-52149-1.00187-7 · Cited by 3
Das, M., & Dam, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04128-8 · Cited by 2
“Nonetheless, some clinical cases were reported with Saccharomyces sp. infection (Enache-Angoulvant and Hennequin 2005; Furuya et al. 2023; Nawaz et al. 2022).”
Recurrent vulvovaginal candidiasis associated with the use of a probiotic supplement
Neal, C. M., Gonzalez, A., Oshinowo, A. E., Fazle, T., & Kako, T. D. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02285 · Cited by 4
“S. cerevisiae has been studied as an oral probiotic with proven migration to the vagina and intestinal tract after oral consumption [4] .”
InfluentialStewart, A. G., Laupland, K. B., Edwards, F., Slavin, M. A., & Chen, S. C. ‐. (2025) · Mycoses · doi:10.1111/myc.70093 · Cited by 2
“S. cerevisiae generally has low MIC values for triazole and polyene antifungals, with less predictable in vitro activity with echinocandins [10].”
Mechanisms of Thermotolerance and Thermotolerant Yeasts: Properties and Applications
Sibirny, A. А., Ruchała, J., Vasylyshyn, R. V., Péter, G., & Dmytruk, K. V. (2025) · Springer eBooks · doi:10.1007/978-3-031-97453-3_2 · Cited by 6
Harmath, A., Vass, L. T., Jakab, Á., Tóth, Z., Bozó, A., Majoros, L., Pfliegler, W. P., & Kovács, R. (2026) · Mycopathologia · doi:10.1007/s11046-026-01080-7 · Cited by 2
“Predisposing factors for invasive S. cerevisiae infection substantially overlap with those associated with candidaemia, including intensive care unit (ICU) admission, total parenteral nutrition, central venous catheterization, gastrointestinal surgery, and neutropenia [4, 5].”
InfluentialProbiotic Yeasts and Bacteria: A Complementary Approach to Gut Health
Cicero, A. F. G., Bartoli, C., Lluís-Ganella, C., & Fabrizzi, P. (2026) · Microorganisms · doi:10.3390/microorganisms14081763 · Cited by 2
Kanagasabapathy, G., BRITTO, S. J., & Anbazhagan, V. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.132315 · Cited by 2
Nawaz, H., Choudhry, A. A., & Morse, W. (2022) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-022-00120-0 · Cited by 2
“In 2005, a review of case reports regarding Saccharomyces cerevisiae infection discovered that the majority of infectivity came from intravascular catheter and antibiotic therapy [2].”
An improved YOLOv3 model for detection of invasive Saccharomyces Cerevisiae infections
Li, G., Li, S., Fang, X., Luan, X., & Liu, F. (2024) · Multimedia Tools and Applications · doi:10.1007/s11042-024-19649-z · Cited by 2
Barna, B., Caldas, L. A., Monteiro, J., dos Santos, A. L., Pascon, R. C., Vallim, M. A., Ferreira, M. J. P., Gonçalves, S. S., Santos, G., Rodrigues, A. M., et al. (2024) · Journal of Fungi · doi:10.3390/jof11010022 · Cited by 2
“Additionally, some strains of Saccharomyces cerevisiae have been responsible for invasive infections more frequently in recent years in patients with underlying diseases with opportunistic infections, mainly in immunodepen-dent individuals [5,6].”
Disseminated yeast (Order Saccharomycetales) infection in a Muscovy duckling (Cairina moschata).
Ravi, M., Hill, J. E., Fernando, C., & Wobeser, G. A. (2016) · PubMed Central · Cited by 2
Clostridium-difficile-Infektion bei geriatrischen Patienten
Simmerlein, R., Basta, A., & Gosch, M. (2016) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-016-1143-9 · Cited by 2
“bei gebrechlichen und immundefizienten Patienten auftraten [120, 121].”
Probiotics and Synbiotics for Management of Infantile Colic
Ahanchian, H., & Javid, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805186-3.00011-4 · Cited by 4
Probiotic Yeasts in Human Welfare
Choudhary, V. K., Vohra, A., Madan, A., & Satyanarayana, T. (2017) · Springer eBooks · doi:10.1007/978-981-10-2621-8_5 · Cited by 3
Vélez, V., Carrasquillo-Carrión, K., Santini-González, J., Ramos-Valerio, Y. A., Vázquez-Quiñones, L. E., Roche-Lima, A., Rodríguez-Medina, J. R., & Parés-Matos, E. I. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.01.001 · Cited by 3
Kozlov, R. S., Shelygin, Y. A., Veselov, A. V., Dekhnich, A. V., Zubareva, N., Ershova, O. N., Кулабухов, В. В., Попов, Д. А., Reshedko, G., & Yakushin, S. B. (2018) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2018.2.76-124 · Cited by 2
Stolarz, W., Piotrowski, D., Blaszkowska, M., Oczko-Grzesik, B., Jaroszewicz, J., Kepa, L., Sobala‐Szczygieł, B., Piasecki, M., & Boroń‐Kaczmarska, A. (2020) · Przeglad Epidemiologiczny · doi:10.32394/pe.74.01 · Cited by 2
A 40-Year-Old Man With Persistent Febrile Neutropenia and Subsequent Rash
Homji, Z. M., North, D. L., Stewart, J., Moir, D., Kalff, A., Fleming, S. A., Ananda-Rajah, M. R., Fuller, A., & Morrissey, C. O. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa562 · Cited by 2
Microorganisms from hands of traditional Chinese medical doctors in a central hospital environment
Sun, Y., Yu, L., Sun, M., & Tong, Y. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v13i1.13 · Cited by 2
Probiotics and Prebiotics in Pediatric Diarrheal Disorders
Vandenplas, Y., Hauser, B., Greef, E. D., Devreker, T., & Veereman-Wauters, G. (2013) · CRC Press eBooks · doi:10.1201/b15561-15 · Cited by 2
Prebiotics, Probiotics, and Synbiotics
Rabizadeh, S., MILLER, M. A., & Sears, C. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00011-4 · Cited by 2
Antimicrobial Stewardship in Immunocompromised Hosts
Vindenes, T., Melinscak, H., Linder, K. E., & Alsoubani, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-21710-4_7 · Cited by 3
A Rare Colonization in Peritoneum After Blunt Abdominal Trauma: S. putrefaciens and S. cerevisiae
Bulat, O., Bulat, C., Blaj, M., Lupuşoru, S. I., & Scripcariu, V. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2017.0773 · Cited by 2
“Uncommon yeast infections, such as Saccharomyces, although rare, are increasing, being isolated in up to 4% of blood cultures (6).”
BackgroundGonsalez, C. R., da Silva, G. P., Ralio, R. B., Santos, N. T., Boccardo, E. J., Medeiros, L. A., & Mendonça, M. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n1-010 · Cited by 2
Liang, Y., Jiang, Z., Fu, Y., Lu, S., Miao, Z., Shuai, M., Liang, X., Gou, W., Zhang, K., Shi, R., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400022 · Cited by 1
Evaluation of the Efficacy of Three Antagonistic Bacteria Strains in the Management of Fire Blight
Zhang, J., Zhang, Z., Wen, Y., Zhu, J., Wufuerjiang, A., & Tian, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094438 · Cited by 1
Minty, M., Lê, S., Addi, M., Canceill, T., Thomas, C., Loubières, P., Burcelin, R., & Blasco‐Baqué, V. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10017-w · Cited by 1
“…reports have documented adverse events such as Lactobacillus bacteremia and Saccharomyces boulardii fungemia in immunocompromised or critically ill patients, indicating that live microbes administered orally can translocate systemically under conditions of impaired barrier function [145, 146].”
Emerging opportunistic yeast infections – literature review
Мирчевска, Г. (2025) · Archives of Public Health · doi:10.3889/aph.2025.6546 · Cited by 3
Yoshinaga, S., Watanabe, M., Ito, H., Hatakeyama, S., Saitou, Y., Yamamura, R., Hashimoto, N., Nanmoku, T., Ohkusu, K., & Suzuki, H. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101821 · Cited by 1
Safety and Effectiveness of Probiotic Preparations: A Contemporary Review
Shorabaev, E., Sadanov, A. K., Baimakhanova, B. B., Ратникова, И. А., Xetayeva, G., Akhelova, S., & Turgumbayeva, A. (2026) · Diseases · doi:10.3390/diseases14090316 · Cited by 1
Zupan, J., Tomičić, Z., & Raspor, P. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2324-y · Cited by 1
“) [9–11].”
Two Cases ofSaccharomyces cerevisiaeFungemia in Patients with Hematologic Malignancies
Lee, H. Y., Kim, J. H., Kim, S. J., Lee, H.-J., Kwon, J.-C., Park, Y.-J., Lee, D., Kim, Y.-J., & Min, C. (2012) · Infection and Chemotherapy · doi:10.3947/ic.2012.44.6.477 · Cited by 1
Use of Cultured Yogurt with Probiotics Causing Septic Shock and Intra-abdominal Abscesses
Fernandez, J., Farhoud, M., Assi, M., & Kallail, K. J. (2015) · Kansas Journal of Medicine · doi:10.17161/kjm.v8i2.11524 · Cited by 1
Infection Due to Non-Candidal Yeasts
Vázquez, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_9 · Cited by 1
“Diagnosis is generally established by histopathology, because Saccharomyces can colonize the respiratory tract without producing invasive disease ( 20 ,29,33).”
BackgroundResultInfluentialESCMID/ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast
Arendrup, M. C., Boekhout, T., Akova, M., & Cornely, O. A. (2013) · Cited by 1
MICROORGANISMS FROM HANDS OF TRADITIONAL CHINESE MEDICAL DOCTORS IN A CENTRAL HOSPITAL ENVIRONMENT
Sun, Y., Yu, L., Sun, M., & Tong, Y. (2015) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v13i1.13 · Cited by 1
Saccharomyces boulardii: Time for Change in the Age of Cost-Effective Medicine
Bell, S. J. (2012) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000e117 · Cited by 1
“boulardii is generally safe for all patients except those who are extremely immune-compromised, or those with central lines [15-17].”
BackgroundPrebiotics and Probiotics in Infant Formulae
Boehm, G., Knol, J., & Wind, R. D. (2009) · CRC Press eBooks · doi:10.1201/9781420062151.ch15 · Cited by 1
Statine und Probiotika in der Prävention urologischer Erkrankungen
Fischer, C. G., & Altwein, J. E. (2007) · Der Urologe · doi:10.1007/s00120-007-1341-6 · Cited by 1
“Eine Arbeitsgruppe aus WHO und FAO („Food and Agriculture Organization“ der Vereinten Nationen) hat Leitlinien für diesen Prozess erstellt [9], (.”
BackgroundZhang, S. X., & Wiederhold, N. P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0030-2016 · Cited by 1
“Saccharomyces cerevisiae is ubiquitous in nature and can be found in soil and on plants and fruits (28).”
BackgroundInfluentialDetection of invasive Saccharomyces cerevisiae infections based on convolutional neural network
Li, S., Du, M., Liu, F., & Li, G. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0408 · Cited by 1
Unusual yeasts isolated from immunocompromised patients
Kasim, Z. S., & Yehia, M. M. (2013) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2013.066861 · Cited by 1
Steroid-binding receptors in fungi: implication for systemic mycoses
Chadeganipour, M., & Mohammadi, R. (2015) · Current Medical Mycology · doi:10.18869/acadpub.cmm.1.2.46 · Cited by 1
“A particular feature of such infections is their association with a probiotic preparation of Saccharomyces for treatment various diarrheal disorders [16-19].”
Background
Metadata
- Authors
- Enache-Angoulvant, A., & Hennequin, C.
- Affiliations
- Hôpital Tenon (FR)
- Corresponding author
- Hennequin, C.
- ORCID
- Hennequin, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 41
- Issue
- 11
- Pages
- 1559-1568
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168407031
- Cited by
- 369
- References
- 88
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 10 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 23 · 2017: 34 · 2016: 19 · 2015: 23 · 2014: 14 · 2013: 23 · 2012: 18
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Saccharomyces cerevisiae, Saccharomyces boulardii, invasive candidiasis, fungemia, emerging fungal pathogens, amphotericin B susceptibility, fluconazole, central venous catheters, antibiotic therapy, immunocompetent patient
- MeSH terms
- Female, Humans, Male, Mycoses, Risk Factors, Saccharomyces
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.